PLA blocks was confirmed from their respective methylene and carbonyl peaks in FTIR spectra. 3 The peaks near 2700-3100 cm -1 and 1450 cm -1 (-CH stretching from -CH2 groups) were contributions from methylene groups of the PEG. The peak at 1750 cm -1 were contributions by the carbonyl stretching in the ester groups of the PLA block ( Figure S1(c) ). The polymers were further characterized using proton nuclear magnetic resonance ( 1 H-NMR) spectroscopy, where the proton contributions from PLA block (-CH ~5.2 ppm and -CH3 ~1.5 ppm) and PEG block (-CH2 ~3.6 ppm) ( Figure S1(d) ). Therefore, from GPC results in conjunction with FTIR and GPC characterization verified the formation of the diblock copolymer.
Synthesis of biotin functionalized diblock copolymer (biotin-PEG-PLA).
Biotinylated poly(ethylene glycol-block-lactic acid) (biotin-PEG-PLA) was synthesized by covalently coupling biotinylated poly(ethylene glycol)-amine (biotin-PEG-NH2, MW ~5,000 Da) with acidterminated poly(lactic acid) (PLA-COOH, MW ~18,000-24,000 Da) ( Figure S2(a) ). The reactant polymers (biotin-PEG-NH2 and PLA-COOH) were dissolved in DCM (polymer concentration ~2% w/v) and kept sealed under a nitrogen atmosphere. N-N'-dicyclohexylcarbodiimide (DCC) was added dropwise (PLA:DCC molar ratio ~1:2) to the polymer solution and the reaction was allowed to proceed for 24 hours.
Purification and Characterization of biotin-PEG-PLA copolymer. The reaction mixture was filtered to remove by-products (like dicyclohexylurea) formed during the course of reaction, followed by precipitation twice in cold diethyl ether. Any trace solvent residue in the precipitated product was removed by rotary evaporation. Further, to remove any unreacted biotin-PEG-NH2 chains from the desired biotin-PEG-PLA product, the obtained polymer was dissolved in acetone and precipitated twice in cold deionized water. 4 The precipitate was centrifuged to collect the product, followed by lyophilization to remove any residual water. The purified product (biotin-PEG-PLA) was characterized using GPC and 1 H-NMR.
The presence of biotin was quantified using the 2-(4-hydroxyphenylazo) benzoic acid Radiolabeling streptavidin. Protein streptavidin was radiolabeled ( 125 I-Streptavidin) using Iodogen® iodination reagent. Iodogen® (1,3,4,6-tetrachloro-3α-6α-diphenylglycouril) was added to a glass tube (2 mg/ml in chloroform, 200 μl) and was evaporated off using dry nitrogen gas to form a thin coat over the tube wall. To the Iodogen ® coated test tube, streptavidin (1mg/ml in PBS, 100 μl) and radioactive iodine ( 125 I) were added (~30 μCi) and incubated for at least 5 minutes enabling iodination of tyrosyl groups in streptavidin. 6 The free iodine was removed from radiolabeled streptavidin ( 125 I-Streptavidin) by centrifugation of the solution through gel filtration columns (Biorad, Hercules, CA, Biospin ® 6 Tris columns).
To estimate free iodine and thereby the amount of radiolabel incorporated in protein streptavidin, a trichloroacetic acid (TCA) precipitation method was used. To the radiolabeled streptavidin (1 mg/ml in PBS, 2 μl), TCA (20% w/v in DI water, 1 ml) and bovine serum albumin (BSA) (5% w/v in PBS, 1 ml) were added and incubated for at least 10 minutes. TCA addition readily precipitates the protein (BSA and radiolabeled streptavidin) from supernatant containing free iodine. The precipitate was pelletized by centrifugation and the supernatant was collected. By measuring radioactive gamma counts (Perkin Elmer 2470 Wizard 2 ) from the supernatant and precipitate separately, the extent of free iodine and the amount of radiolabel incorporated was determined.
Evaluation of non-specific network growth from biotin-micelle depositions without complementary streptavidin additions. By monitoring biotin-micelle depositions without streptavidin would help determine whether biotin moieties by themselves would cause intermicelle complexation and grow into networks. To examine such a possibility and to see if nonspecific interactions significantly affect network formation, LBL networks were grown using biotinylated spherical micelles (biotin-SM) without streptavidin. These networks were formed by adopting a similar procedure as described under micelle-LBL network formation, but without providing intermittent streptavidin additions. Biotin-SM (without streptavidin additions) showed poor ability to form networks without the affinity-based crosslinker streptavidin ( Figure S6 ).
This observation was visually confirmed via fluorescence imaging ( Figure S7) , suggesting an insignificant impact of non-specific interactions on network formation.
Evaluating non-specific crystal violet staining on micelle-LBL networks without any bacterial growth. A similar procedure was adopted as described under bacterial growth quantification using crystal violet assay. 7, 10, and 14 layered micelle-LBL networks (SM-LBL, FM-LBL), which possess relatively higher network-surface coverage was used. These micelle-LBL were subjected to crystal violet staining without addition of bacteria to evaluate the possibility of non-specific staining of the micelles. The staining of these FM-LBL and SM-LBL networks were compared to those of control substrate surfaces (polystyrene surface) with and depositions of Biotin-SM without streptavidin, and micelles without biotin moieties with streptavidin additions were performed separately. These controls lacked either biotin or streptavidin affinity moieties, hence insignificant network formation trends were observed even with increasing NoL. This is unlike the LBL depositions of biotin-SM and streptavidin that showed significant LBL growth because of their ability to effectively crosslink via the biotin-streptavidin affinity linkages. However, blank substrates with bacterial growth showed a significantly higher staining compared to networks and blank substrate without bacteria. This clearly indicates the specificity of crystal violet for staining bacterial components. A 2-sample t-test performed using a statistical software (Minitab), found differences between networks and substrate (without bacteria) to be insignificant, while between systems (with and without bacterial growth) to be significant. The differences were considered significant (*) only when p-value < 0.05.
